John MacKay - Sartorius Aktiengesellscha Executive
| SARTF Stock | USD 182.98 9.77 5.07% |
Executive
Mr. John Gerard MacKay was Member of the Executive Board, Head of the Lab Products Services Division of Sartorius Aktiengesellschaft since January 1, 2019. He joined Sartorius in 2015 from the acquisition of BioOutsource, where he had been its CEO since 2009. Prior to his tenure with BioOutsource, he held international senior level positions in Sales and Marketing at several companies, among them at the U.S. life science company Millipore. At Sartorius, Mr. Mackay as Head of Marketing, Sales and Services of the Lab Products Services Division drove the momentum of the division new strategic direction towards the biopharmaceutical market and its respective applications and technologies. He holds a BS Honors degree in biochemistry and a Master in education. since 2019.
| Age | 61 |
| Tenure | 5 years |
| Phone | 49 551 308 0 |
| Web | https://www.sartorius.com |
Sartorius Aktiengesellscha Management Efficiency
The company has return on total asset (ROA) of 0.106 % which means that it generated a profit of $0.106 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.3386 %, meaning that it generated $0.3386 on every $100 dollars invested by stockholders. Sartorius Aktiengesellscha's management efficiency ratios could be used to measure how well Sartorius Aktiengesellscha manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 5 records | EXECUTIVE Age | ||
| Stefano Grassi | EssilorLuxottica Socit anonyme | 50 | |
| Mahesh Lawande | Precision Optics, | 51 | |
| Dorothy Ressel | Top Glove | N/A | |
| Clay Schwabe | Precision Optics, | N/A | |
| Jeffrey DiRubio | Precision Optics, | N/A | |
Management Performance
| Return On Equity | 0.34 | |||
| Return On Asset | 0.11 |
Sartorius Aktiengesellscha Leadership Team
Elected by the shareholders, the Sartorius Aktiengesellscha's board of directors comprises two types of representatives: Sartorius Aktiengesellscha inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sartorius. The board's role is to monitor Sartorius Aktiengesellscha's management team and ensure that shareholders' interests are well served. Sartorius Aktiengesellscha's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sartorius Aktiengesellscha's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Rene Faber, Member of the Executive Board, Head of the Bioprocess Solutions Division | ||
| Petra Kirchhoff, Member of the Supervisory Board, Vice President of Corporate Communications & Investor Relations | ||
| Rashid Maqbool, Head USA | ||
| Manfred Werner, Sr Auditing | ||
| John MacKay, Member of the Executive Board, Head of the Lab Products & Services Division | ||
| Patricia Spannagel, Head Goettingen | ||
| Mei Wang, Head China | ||
| Joachim Kreuzburg, Chairman of the Executive Board, CEO, Executive for Labor Relations | ||
| Rainer Lehmann, CFO, Member of the Executive Board | ||
| Manohar Kuppusami, Head India |
Sartorius Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Sartorius Aktiengesellscha a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.34 | |||
| Return On Asset | 0.11 | |||
| Profit Margin | 0.13 % | |||
| Operating Margin | 0.27 % | |||
| Current Valuation | 27.76 B | |||
| Shares Outstanding | 34.23 M | |||
| Shares Owned By Insiders | 84.78 % | |||
| Shares Owned By Institutions | 3.73 % | |||
| Price To Earning | 58.19 X | |||
| Price To Book | 11.12 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Sartorius Pink Sheet
Sartorius Aktiengesellscha financial ratios help investors to determine whether Sartorius Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sartorius with respect to the benefits of owning Sartorius Aktiengesellscha security.